IMV Inc IMVIQ

RE:RE:RE:Outta Here...

[qwerty22]

Not promising anything but some news flow might come around AACR, so 10th March for abstract publication and April for conference, I'm hoping that's when they clarify the ovarian situation. The FDA regulatory process mostly runs on a 60 day turnover and they've been sitting on the dlbcl pd-l1 biomarkers data for some time now and been signalling they have worked out the path forward since the start of 2021 so take your own guess on the timing of that important step forward.

Kazam1961 wrote:
Europe...I believe you have a GOOD entry point. For myself, I got into this stock at too high of a price. I feel I can throw this  money into some of my other growing stocks for awhile. While I believe this company has  potential for a significant breakout, I have to stick to my guidelines....I am more of a swing trader than a long player. GLTA ...PS... I hope you are correct!